eif3c在人脑胶质瘤中的表达及其对脑胶质瘤u87mg细胞增殖作用的体内外研究

《eif3c在人脑胶质瘤中的表达及其对脑胶质瘤u87mg细胞增殖作用的体内外研究》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、授予单位代码10089学号或申请号2012丨062HebeiMedicalUniversity博士学位论文科学学位EIF3C在人脑胶质瘤中的表达及其对脑胶质瘤U87MG细胞增殖作用的体内外研究研究生：郝进敏导师：焦保华教授专业：外科学二级学院：第二医院2015年4月河北医科大学学位论文使用授权及知识产权归属承诺本学位论文在导师（或指导小组）的指导下，由本人独立完成。本学位论文研究所获得的研究成果，其知识产权归河北医科大学所有。河北医科大学有权对本学位论文进行交流、公幵和使用。凡发表与学位论文主要内容相关的论文

2、，第一署名为单位河北医科大学，试验材料、原始数据、申报的专利等知识产权均归河北医科大学所有。否则，承担相应综律;靑任。^、.1-•.t>•：-'^g级学院领导盖章：4..研究生河北医科大学研究生学位论文独创性声明本论文是在导师指导下进行的研究工作及取得的研究成果，除了文中特别加以标注和致谢等内容外，文中不包含其他人已经发表或撰写的研究成果，指导教师对此进行了审定。本论文由本人独立撰写，文责自负。研究生签名^导师签章年上月乂7日目录中文摘要····································

3、·············································1英文摘要·················································································9英文缩写···············································································21研究论文EIF3C在人脑胶质瘤中的表达及其对脑胶质瘤U87MG细胞增殖作用的体内

4、外研究引言···············································································24第一部分EIF3C在人脑胶质瘤和正常脑组织中的表达研究前言···············································································26材料与方法························································

5、··············27结果···············································································33附图···············································································36附表·········································································

6、······39讨论···············································································43小结···············································································46参考文献·········································································47第二部分

7、EIF3C对脑胶质瘤U87MG细胞增殖作用的体外研究前言···············································································52材料与方法······································································53结果·····································································

8、··········86附图···············································································89附表···············································································97讨论·····················